A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump
Status:
Completed
Trial end date:
2017-06-19
Target enrollment:
Participant gender:
Summary
This study will be conducted in participants with type 1 diabetes mellitus to investigate how
the human body processes LY900014, a new blood sugar lowering insulin, and its effect on
blood sugar levels when it is delivered via an insulin pump. Side effects and tolerability
will be documented. The study will last about 4 to 11 weeks for each participant.